Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Fulcrum Pharma plc]

29 Apr 2010 13:03

RNS Number : 0529L
Bluehone Investors LLP
29 April 2010
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Bluehone Investors LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Fulcrum Pharma Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

27/04/2010 (opening position)

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

25,006,986

14.05

-

-

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

25,006,986

14.05

-

-

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

-

Details, including nature of the rights concerned and relevant percentages:

-

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

-

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

-

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

-

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

-

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

28/04/2010

Contact name:

Richard Morrison,

F&C Asset Management plc,

on behalf of Bluehone Investors LLP

Telephone number:

0131 718 1093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEAALNAEAEEFF
Date   Source Headline
4th Oct 20215:47 pmRNSExercise of Options and Total Voting Rights
4th Oct 20211:10 pmRNSExercise of Options and Total Voting Rights
30th Sep 20212:45 pmRNSTotal Voting Rights
29th Sep 20215:55 pmRNSResult of AGM
29th Sep 20217:00 amRNSAGM Statement
24th Sep 20214:05 pmRNSResults of Placing
24th Sep 20213:00 pmRNSExercise of Options and Proposed Secondary Placing
16th Sep 20215:57 pmRNSExercise of Options and Total Voting Rights
14th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
10th Sep 20215:24 pmRNSExercise of Options and Total Voting Rights
7th Sep 20217:00 amRNSNotice of Annual General Meeting
2nd Sep 20212:41 pmRNSExercise of Options and Total Voting Rights
1st Sep 20215:01 pmRNSTotal Voting Rights
27th Aug 20219:50 amRNSDirector/PDMR Shareholding
26th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
17th Aug 20217:00 amRNSFinal Results
5th Aug 20217:00 amRNSChange of Nomad and Broker
28th May 20217:00 amRNSTrading Update
30th Apr 20215:00 pmRNSTotal Voting Rights
23rd Apr 20213:30 pmRNSGrant & exercise of options and TVR
23rd Apr 20217:00 amRNSTrading Update
7th Apr 20215:09 pmRNSHolding(s) in Company
31st Mar 20215:00 pmRNSTotal Voting Rights
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSHolding(s) in Company
24th Feb 20213:55 pmRNSExercise of options and Director dealings
22nd Feb 20217:00 amRNSExercise of options and Director dealings
9th Feb 20214:35 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSHalf-year Report
25th Nov 20209:53 amRNSResult of Annual General Meeting
25th Nov 20207:00 amRNSAGM statement and Trading Update
2nd Nov 20202:01 pmRNSPosting of Annual Report & Notice of AGM
15th Oct 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSTrading update and extension of results deadline
28th Aug 20205:15 pmRNSTotal Voting Rights
20th Aug 20202:05 pmRNSSecond Price Monitoring Extn
20th Aug 20202:00 pmRNSPrice Monitoring Extension
20th Aug 20201:18 pmRNSHolding(s) in Company
20th Aug 20208:01 amRNSCompletion of banking facilities & trading update
10th Aug 202011:05 amRNSSecond Price Monitoring Extn
10th Aug 202011:00 amRNSPrice Monitoring Extension
6th Aug 20208:41 amRNSResult of fundraise & Director shareholdings
6th Aug 20207:00 amRNSTrading update and proposed fundraise
30th Apr 20204:35 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSTrading update
17th Mar 202011:06 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
16th Mar 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.